These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5482214)

  • 21. [Sero-immunological studies of measles in infants].
    Buşilă VT; Vasilescu I; Fitărău A; Moldovan E; Olaru G
    Stud Cercet Virusol; 1973; 24(4):281-4. PubMed ID: 4730452
    [No Abstract]   [Full Text] [Related]  

  • 22. [Measles prevention with vaccination. Indications and methods of execution in minor subjects with tubercular processes i the first 2 phases of the primary cycle].
    De Franciscis V; Montella A
    Arch Tisiol Mal Appar Respir; 1965 Mar; 20(3):183-90. PubMed ID: 5306079
    [No Abstract]   [Full Text] [Related]  

  • 23. [Atypical measles experienced in 1970].
    Seki T; Hara M; Miyazaki Y; Chiba H; Yokota K
    Nihon Shonika Gakkai Zasshi; 1971 Jun; 75(6):440-5. PubMed ID: 5104630
    [No Abstract]   [Full Text] [Related]  

  • 24. Altered reactivity to measles virus. Skin test reactivity and antibody response to measles virus antigens in recipients of killed measles virus vaccine.
    Fulginiti VA; Arthur JH
    J Pediatr; 1969 Oct; 75(4):609-16. PubMed ID: 5809839
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoglobulins on measles vaccine inoculation or measles virus infection--particularly, on 2-mercaptoethanol sensitive and resistant antibodies.
    Arai M; Nakamura M
    Acta Paediatr Jpn; 1970 Dec; 12(2):9-15. PubMed ID: 4100594
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 27. [The critical titer of hemagglutination inhibiting (HAI) antibody in measles infection].
    Xu FG
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Apr; 4(2):83-8. PubMed ID: 6883489
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody titres three years after immunization with a live measles vaccine.
    Schumacher H; Welbers de Liddle IB
    Ger Med Mon; 1971; 1(1):37-41. PubMed ID: 5579592
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of 3 measles vaccines. IV. Evaluation of effectiveness on the basis of epidemiologic observations].
    Przegl Epidemiol; 1971; 25(1):1-10. PubMed ID: 5088689
    [No Abstract]   [Full Text] [Related]  

  • 30. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
    Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
    Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the combined use of killed and live measles vaccines. V. Five year follow-up.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):179-83. PubMed ID: 5496091
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative trial of further attenuated measles vaccines.
    Hendrickse RG; Montefiore D; Sherman P; Peradze T
    Br Med J; 1966 Mar; 1(5490):779-81. PubMed ID: 5910109
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and immunological prospective study of the measles live virus vaccine].
    Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
    Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunologic structure of the population characterizing measles susceptibility and its change with massive active immunization].
    Tsipershtein MIa; Shekhter AB
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):39-42. PubMed ID: 5037761
    [No Abstract]   [Full Text] [Related]  

  • 35. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC].
    Adam E; Fosenbauerová E; Domorázková E; Kratochvílová M; Kubátová E; Mares I; Drevo M; Svandová E
    Cesk Pediatr; 1968 Jul; 23(7):581-93. PubMed ID: 5681931
    [No Abstract]   [Full Text] [Related]  

  • 37. Measles antibodies in multiple sclerosis patients and controls (biostatistical evaluation).
    Mai K
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:109-16. PubMed ID: 5373022
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the sensitivity of a passive hemagglutination test in the detection of antimeasles antibodies.
    Ghyka GR; Cernescu C; Cajal N
    Rev Roum Virol (1972); 1973; 10(4):295-300. PubMed ID: 4207146
    [No Abstract]   [Full Text] [Related]  

  • 39. Ineffectiveness of historical data in predicting measles susceptibility.
    Scott RM; Butler AB; Schydlower M; Rawlings P
    Pediatrics; 1984 Jun; 73(6):777-80. PubMed ID: 6728580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.